Compare PRCT & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRCT | NFJ |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | N/A |
| Metric | PRCT | NFJ |
|---|---|---|
| Price | $25.85 | $12.48 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $35.44 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 174.3K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.01% |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $32.85 | N/A |
| Revenue Next Year | $24.66 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $19.35 | $10.02 |
| 52 Week High | $64.89 | $13.92 |
| Indicator | PRCT | NFJ |
|---|---|---|
| Relative Strength Index (RSI) | 45.68 | 25.82 |
| Support Level | $19.35 | N/A |
| Resistance Level | $29.24 | $12.48 |
| Average True Range (ATR) | 1.94 | 0.18 |
| MACD | 0.24 | -0.08 |
| Stochastic Oscillator | 56.22 | 5.00 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.